Status: Recruiting
GPC3-Targeted PET/CT in Hepatocellular Carcinoma
The objective of the study is to evaluate the diagnostic value of GPC3-targeted PET/CT in patients with suspected or histologically/clinically confirmed hepatocellular carcinoma, and to compare with contrast-enhanced MRI.
Participants needed: 40
Trial details
Age: 18-90Biological sex: AllType: InterventionalSponsor: The First Affiliated Hospital of Xiamen UniversityUpdated: Sep 10, 2026Locations: 1
Eligibility criteria
Adult patients (aged 18 years or older); [+3]
Lack of contrast-enhanced liver MRI or an interval of more than 14 days between... [+3]